Clinical trial NCT06578494: The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients
Official title: The Efficacy of Implementing Nurse-performed Ultrasound-guided Peripheral Intravenous Access in Oncology Patients: a Prospective Interventional Clinical Study
Study type: INTERVENTIONAL
Overall status: NOT_YET_RECRUITING
Phase: NA
Conditions: Supportive Care
Keywords: Ultrasonography
Intravenous
Oncology
Lead sponsor: Faroese Hospital System
Sponsor class: OTHER
Collaborators: name: National Hospital of the Faroe Islands
name: University of the Faroe Islands
name: University of Aarhus
First posted: 2024-08-29
Enrollment: 40
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NON_RANDOMIZED
Intervention model: FACTORIAL
Intervention model description: This is a before and after study, where the patients pre-implementation stage receive intravenous access via the traditional palpation technique and in the post-implementation stage receive ultrsound-guided intravenous cannulation.
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this study is to investigate the clinical efficacy of nurse-performed ultrasound-guided intravenous access in oncology patients on the oncological outpatient unit in the National Hospital of the Faroe Islands.

Detailed description: This project is prospective, interventional, clinical study aligned in four different time stages.

In the first stage, the pre-implementation stage, procedures are as usual, where the patient receives intravenous access via the use of the traditional palpation technique and data will be registered. In the next stage, the training stage, the nurses on the oncological outpatient unit will be trained in the use of the ultrasound-guided technique to place peripheral intravenous catheters and will be supervised by specialists in ultrasound. In the third stage, the implementation stage, the nurses will use the ultrasound technique as a daily routine in their practice. In the fourth stage, the post-implementation stage, the same data registration as in the first stage will be registered (see outcome measures) and the results will be compared in order to see the efficacy before and after implementation of ultrasound guidance. It is estimated a total sample of 100 cannulation procedures with approximately 30 patients needed in the pre-implementation and post-implementation stages.

Eligibility criteria: Inclusion Criteria:

* Cancer patients admitted to the oncological outpatient unit are eligible for inclusion if they are scheduled for treatment with chemotherapy requiring placement of peripheral intravenous catheter, aged 18 years or older, and reside in the Faroe Islands.

Exclusion Criteria:

* Lack of informed consent and mental incapacity.

Primary outcomes:
measure: First attempt success rate
timeFrame: The time frame for the outcome measure first attempt succes rate for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
Secondary outcomes:
measure: Number of skin punctures
timeFrame: The time frame for the outcome measure number of attempts for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
measure: Patient's satisfaction
timeFrame: The time frame for the outcome measure patient´s satisfaction for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
measure: Patient's experience of pain
timeFrame: The time frame for the outcome measure patient´s experience of pain for each participant is estimated 1 hour in the pre-implementation stage and 1 hour in the post-implementation stage.
measure: Durability
timeFrame: The time frame for the outcome measure durability for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage.
measure: Intravenous complications
timeFrame: The time frame for the outcome measure intravenous complications for each participant is estimated 4 hours in the pre-implementation stage and 4 hours in the post-implementation stage.
Other outcomes:
Locations:
Study officials:
affiliation: Aarhus University Hospital
name: Peter Juhl-Olsen, MD, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of the Faroe Islands
name: August Gabriel Wang, MD, DMSc
role: PRINCIPAL_INVESTIGATOR
affiliation: Department of Research, the National Hospital of the Faroe Islands
name: Lisa Maria Anderssen, RN, MHS
role: PRINCIPAL_INVESTIGATOR
References: